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Abstract 
Background: Correlation of cytologic and ultrasound findings is  extremely valuable 
for the cytopathologist in management of thyroid nodules. 
Methods: Ultrasound scans (US) of all thyroid FNA taken over a 13 month period 
and reported by a single cytologist were reviewed at the time of reporting, focusing 
on aspirates that were non-diagnostic/unsatisfactory, Bethesda Class I, UK Royal 
College of Pathologists Class Thy1 or Thy1c. 
Results: 68 (40.7%) FNA cases were classified as Thy1, equivalent to Bethesda 
Class I. US of 3 Thy1 cases were not available for  review. On cytologist US review 9 
cases were classified as pure cystic, 28 as mixed cystic/solid, 12 as predominantly 
solid/focally cystic, and 16 as purely solid.  27 (41.5%) of cases on cytological 
assessment were Thy1 and showed no evidence of a cyst on US, 17 (26.1%) were 
Thy1/Thy1C showing features suggestive of a possible cyst and 21 (32.3%) were 
Thy1c showing definite features of a cyst. 15 of 16 (93.7%) of pure solid cases on 
US were Thy1, equivalent to Bethesda Class I and all 9 (100%) of cases that were 
pure cystic on US were reported as Thy1c- equivalent to Bethesda Category I- cyst 
fluid only (p<0.001). 
Conclusion: Cytopathologist review of thyroid ultrasound scans is extremely useful 
and can be helpful in triaging patients for further management in cases of solid, 
mixed cystic and or/solid, and pure cystic thyroid lesions with non-
diagnostic/unsatisfactory thyroid FNA. 
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Background 
FNA of the thyroid is the principal method for preoperative investigation of thyroid 
nodules. While traditionally thyroid FNA was performed freehand, the majority of 
thyroid FNAs in modern practice are now performed under ultrasound guidance. 
Although institutional practices vary there is a trend toward some cytopathologists 
undertaking their own thyroid  ultrasound examinations, extending the role of the 
cytopathologist [1-3]. However, the majority of practicing cytopathologists do not 
perform thyroid ultrasound examinations at the time of aspiration. There is a wealth 
of information that can be obtained from review of ultrasound scans, available to the 
ultrasonographer, radiologist or clinician undertaking the ultrasound scan although 
not all of this information is easy to convey to the cytopathologist. In North America 
ultrasound scans can be classified using AACE [4], or ATA [5] sonographic criteria 
which convey the ultrasound features and a clinical suspicion risk of an individual 
nodule or lesion. In the UK the 2014 British Thyroid Association Guidelines for 
Management of Thyroid Cancer classifies nodules on a sonographic index of 
suspicion/risk scale of U2 to U5 [6]. Frequently however this does not necessarily 
convey all the relevant information to the cytologist. The author instituted 
cytopathologist review of all thyroid ultrasound scans for patients undergoing thyroid 
fine-needle aspiration in June 2016.The data presented here represents a personal 
13 month experience describing the results achieved and the value of 
cytopathologist performed review of thyroid nodule ultrasound scans for non-
diagnostic/unsatisfactory thyroid FNA. 
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Materials and Methods 
The Department of Pathology and Cytopathology at The Queen Alexandra Hospital, 
Cosham, Portsmouth, UK serves a patient population of around 650,000, 
approximately 2-3% of the UK population. The hospital is a major cancer centre. All 
thyroid fine-needle aspirates are taken by a team of consultant radiologists or trainee 
radiologists working under consultant supervision in the ultrasound rooms in the 
Department of Radiology at Queen Alexandra Hospital, Cosham, Portsmouth. The 
fine-needle aspirates are taken with 23 or 25 gauge needles using capillary action, 
and/or simple suction and direct smears are made onto glass slides and are stained 
with conventional cytological techniques, air dried Giemsa and Papanicolaou stains. 
Liquid-based cytology techniques are not used. Typically 2 to 3 needle passes are 
taken with 3 to 4 slides air dried or alcohol fixed prepared per case. Rapid on-site 
assessment of FNA is not available. As this article describes the results of routine 
day-to-day clinical practice and the results for the patients concerned are 
anonymised it did not require institutional ethical approval. The results presented 
comprise all the fine-needle aspirates personally reported by the author over a 13 
month period from July 1st 2016 to 31st July 2017. For each patient the author 
personally reviewed the ultrasound scans and also the written report of the 
radiologist. The nodules were classified by the cytologist on the basis of the 
sonographic nature of the nodule(s) as follows  
(i) pure cystic lesion 
(ii) mixed cystic/solid nodule 
(iii) predominantly solid nodule with occasional foci of cystic change/and or 
hemorrhage – predominantly solid/focally cystic 
(iv) purely solid nodule- pure solid 
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The cytopathologist also referred to the radiologist’s written ultrasound 
examination report for confirmation. FNA’s reported by other cytopathologists at 
the Department of Pathology Queen, Alexandra Hospital were not included as 
these patients did not undergo review of their ultrasound scans by a 
cytopathologist prior to reporting of the thyroid fine-needle aspiration. The fine-
needle aspirates were classified using The UK Royal College of Pathologists 
terminology. [7]This subdivides the non-diagnostic category for cytological 
diagnosis, Thy1/Thy1c, in a similar manner to other terminology systems such as 
The Bethesda System for Reporting Thyroid FNA Cytology. An FNA is 
considered of adequate epithelial cellularity using the Royal College of 
Pathologists terminology if a sample from a solid lesion has at least 6 groups of 
thyroid follicular epithelial cells across the submitted slides, each with at least 10 
well-visualised epithelial cells. The reason(s) for a non-diagnostic sample may be 
that either  
(i) the sample consists entirely of blood or it is so heavily bloodstained that 
the epithelial cells or colloid cannot be visualised 
(ii) the sample is acellular or too low in follicular epithelial cell yield to allow 
diagnosis 
(iii) the sample cannot be evaluated e.g. due to poor spreading, delayed air 
drying, or fixation artefact, prominent crush artefact or cells trapped in 
fibrin 
In the UK Royal College of Pathologists terminology cyst fluid specimens that do not 
reach the threshold for adequate follicular epithelial cell yield stated above and that 
contain mostly macrophages but abundant colloid can be reported as…’ a sample is 
7 
 
in keeping with fluid from a cyst but there are no epithelial cells or colloid to confirm 
cyst type..’ with use of the category Thy 1c where ‘c’ means a cystic lesion. [7]  
For the purposes of this study if it was absolutely clear that the lesion was cystic 
based on the nature of the cells seen in the relevant slides from the sample 
received it was reported as Thy1c, equivalent to Bethesda Category I cyst fluid 
only. If there was some uncertainty based on the cellular appearances the 
aspirate was reported as Thy1/Thy1c- implying that it was unclear as to whether 
or not the aspirate was from a cystic lesion. If the lesion did not show features of 
a cyst and had less than 6 groups of 10 well preserved epithelial cells across the 
slides or it was technically unsatisfactory for whatever other reason the case was 
reported as Thy1, equivalent to Bethesda category I non-diagnostic.  
Statistical analysis was performed using Statistica Academic version 13.2 Tibco 
Software Inc.,Palo Alto, Ca, USA. 
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Results 
There were, in total, 167 FNA’s from 139 patients were reported with ultrasound 
review over a 13 month period, comprising 68 (40.7%) Thy1 aspirates. 27 (16.2%) 
were Thy1 and showed no cytological features of a cyst, 17 (10.2%) were 
Thy1/Thy1c showing features suggestive of a possible cyst although not conclusive 
for a cyst and 21 (12.6%) were Thy 1c showing definite features indicating a cyst. 
There were 30 Thy 2 aspirates, 7 Thy2c aspirates, 29 Thy3a, 20 Thy3F, 7 Thy4 and 
6 Thy 5 FNA’s. In 3 cases the ultrasound images were not available for review as 
these had not been uploaded onto the computer server at the time of ultrasound 
examination and these images could not be retrieved. Of the 65 remaining cases 
that were either Thy1, Thy1/Thy1c or Thy1c and that  are the basis of this article; 9 
were classified by the author on review of the ultrasound scan as pure cystic, 28 
were classified as mixed cystic/solid, 12 as predominantly solid/focally cystic and 16 
as purely solid (table1). There was no statistically significant trend across the whole 
group of 65 non-diagnostic thyroid FNAs when cases that were either mixed 
cystic/solid or predominantly solid/focally cystic were included, chi-square test NS. If 
the mixed cystic/solid and the predominantly solid/focally cystic cases were excluded 
from the analysis,15 of 16 (93.7%) of the cases that appeared purely solid on 
ultrasound were reported as Thy1-equivalent to Bethesda class I and all 9 cases 
(100%) pure cystic on ultrasound were reported as Thy 1c, equivalent to Bethesda 
class I- ‘cyst fluid only’, Fisher’s exact test p>0.001.  Of the 28 cases that on 
ultrasound appeared mixed cystic/solid 5 were reported as Thy1, 12 as Thy1/Thy1c 
and 11 as Thy1c.  Of the predominantly solid/focally cystic 7 cases were reported as 
Thy1, 4 cases as Thy1/Thy 1c, and 1 case as Thy 1c.  
 
9 
 
Discussion 
This brief study suggests that it can be useful for a reporting pathologist with 
sufficient expertise to review the relevant ultrasound scans of thyroid lesions and 
thyroid nodules if an FNA is considered non-diagnostic/unsatisfactory. The principal 
reason is that solid thyroid lesions on ultrasound should nearly always yield 
diagnostic cellular material or show some other specific lesion. If a thyroid nodule is 
solid and cellular material is absent or lacking this implies that the FNA is likely to be 
unsatisfactory and that the FNA should be repeated. If the lesion is clearly from a 
unilocular/simple cyst on ultrasound and the cytopathologist is aware of this and 
there are no concerning ultrasound features identified by the radiologist or the 
cytopathologist then the lesion is likely to be of very low risk. However cases that are 
part cystic/part solid or predominantly solid with occasional cystic areas are 
potentially more problematic, particularly if the aspirate is taken from a cystic area of 
a larger lesion that is elsewhere solid. These lesions should not be categorised as 
Thy 1c in the UK terminology [7] or Bethesda Category I cyst fluid only [8] as this 
may understate the potential risk of malignancy of these lesions. Cases that are 
interpreted cytologically as purely cystic on FNA cytology, if the ultrasound shows a 
simple unilocular cyst, may after review of the ultrasound scan by a cytopathologist 
need no further follow-up.  Triage of cases to potentially higher-risk lesions that 
require further follow-up and/or re-aspiration and/or possibe surgery can be 
achieved. In this small prospective study all the cases that on ultrasound were purely 
cystic showed appearances in keeping with cyst fluid only, and lesions that on 
ultrasound appeared purely solid on ultrasound were in almost all cases were 
reported as Thy1. 
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It is also worth commenting that in the UK Royal College of Pathologists Terminology 
as also in The Bethesda System for Reporting Thyroid FNA cytology  the 
nondiagnostic/unsatisfactory criteria are virtually identical. In the Bethesda system a 
non-diagnostic/unsatisfactory aspirate typically comprises fewer than six groups of 
well preserved well stained follicular epithelial cells, or is poorly prepared, poorly 
stained, or shows obscured follicular cells, or is a cyst fluid, whether without 
histiocytes or fewer than 6 groups of 10 benign follicular cells [8]. The Bethesda 
System for Reporting Thyroid Cytology: Definitions, Criteria and Explanatory Notes 
states that in the proper clinical setting e.g. ultrasound evidence of a simple 
unilocular cyst, cyst fluid only specimens may be considered clinically adequate even 
though they are reported as non-diagnostic/unsatisfactory [8].  
In summary, in the appropriate clinical setting, cytopathological assessment of   
thyroid FNA can usefully be extended to include the cytologist’s review of the 
ultrasound scans prior to issuing of the cytopathology report, if the cytopathologist 
sufficient expertise and training in ultrasound scan interpretation. 
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